Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. AbCellera Biologics Inc’s current trading price is -48.29% away from its 52-week high, while its distance from the 52-week low is 34.09%. The stock’s price range over this period has fluctuated between $2.34 and $6.05. The company, operating within the financial sector, had a trading volume of approximately 1.68 million for the day, which was noticeably lower than the average daily share volume of 2.35 million over the last 3 months.
AbCellera Biologics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $6.05 on 01/08/24 and a low of $2.34 for the same time frame on 09/10/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
AbCellera Biologics Inc (ABCL) has experienced a quarterly rise of 26.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 924.76M and boasts a workforce of 586 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.72, with a change in price of +0.46. Similarly, AbCellera Biologics Inc recorded 2,226,730 in trading volume during the last 100 days, posting a change of +17.15%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABCL Stock Stochastic Average
Today, AbCellera Biologics Inc’s raw stochastic average for the past 50 days stands at 94.04%, indicating a decline from the raw stochastic average of the last 20 days, which was 98.02%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 77.12% and 66.13% respectively.
ABCL Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 6.86%.However, over the last six months, we can see a weaker performance of 15.53%. Over the last 30 days, the price of ABCL has fallen by 3.33%. And in the last five days, it has surged by 6.13%.
